These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4073 related articles for article (PubMed ID: 6752286)

  • 21. Chemical and biological properties of a purified lymphoreticular-stimulating fraction of Corynebacterium parvum (Propionibacterium acnes type I).
    Adlam C; Reid DE; Marshall AJ; Torkington P
    J Med Microbiol; 1979 Nov; 12(4):429-40. PubMed ID: 513108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical effects of immunopotentiators on tumors and tumor viruses.
    Morahan PS; Schuller GB; Snodgrass MJ; Kaplan AM
    J Infect Dis; 1976 Jun; 133 Suppl():A249-55. PubMed ID: 932503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of Corynebacterium parvum, BCG, OK-432 and Lactobacillus casei on the hepatic drug-metabolizing systems and on the oxygen radical production by fixed macrophages in liver of BALB/c mouse].
    Hashimoto S; Yokokura T; Mutai M
    Yakugaku Zasshi; 1984 Apr; 104(4):356-61. PubMed ID: 6491874
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure to boost the increased clearance of embolic tumor cells from the lung with dose scheduling: Corynebacterium parvum studies.
    Proctor JW; Yamamura Y
    Oncology; 1986; 43(3):192-7. PubMed ID: 3703464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
    O'Neill GJ; Stebbing N
    Br J Cancer; 1980 Feb; 41(2):243-9. PubMed ID: 7370164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of pleural macrophages by intrapleural application of Corynebacterium parvum.
    Basić I; Rodé B; Kastelan A; Milas L
    Adv Exp Med Biol; 1979; 121(A):333-41. PubMed ID: 547729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reversal of surgically induced reticuloendothelial depression.
    Everson NW; Stacey RL; Wood RF; Bell PR
    Clin Exp Immunol; 1979 Jul; 37(1):169-73. PubMed ID: 487654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of phagocytic activity of reticuloendothelial system (RES) by Intralipid: effect of C parvum treatment.
    Kim DK; Pfeifer J
    Surg Forum; 1977; 28():85-7. PubMed ID: 617547
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonspecific immunotherapy of malignant tumors.
    Milas L; Withers HR
    Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G; Shaklee CL; Mak TW; Ulich TR
    Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
    Marconi P; Bistoni F
    Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria.
    Ojo E
    Cell Immunol; 1979 Jun; 45(1):182-7. PubMed ID: 455483
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunomodulators on thymocyte suppressive activity in mice.
    Anaclerio A; Conti G; Moras ML; Maconi A; Spreafico F
    Eur J Cancer (1965); 1978 Aug; 14(8):829-35. PubMed ID: 28950
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose-dependent macrophage stimulation by Corynebacterium parvum.
    Loose LD; Astry CL; Megirian R
    J Immunopharmacol; 1980; 2(3):349-65. PubMed ID: 6821558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 204.